×
About 10,519 results

ALLMedicine™ Intravenous Immunoglobulin Center

Research & Reviews  5,131 results

Intravenous immunoglobulin in COVID-19 associated Guillain-Barré syndrome in pregnancy.
https://doi.org/10.1136/bcr-2021-242365
BMJ Case Reports; Garcia JJ, Turalde CW et. al.

May 12th, 2021 - The COVID-19 pandemic has led to a rise in cases of Guillain-Barré syndrome (GBS). This autoimmune sequela is a manifestation of the neurotropism potential of the virus. At present, knowledge regarding the pathophysiology, clinical features, manag...

Nivolumab induced systemic capillary leak syndrome as an ultra rare life-threatening ph...
https://doi.org/10.2217/imt-2020-0335
Immunotherapy Polishchuk I, Yakobson A et. al.

May 10th, 2021 - Systemic capillary leak syndrome (SCLS) is a life-threatening disease. It is characterized by severe capillary hyperpermeability to proteins resulting in hemoconcentration, hypoalbuminemia and hypovolemic shock. Its treatment remains supportive, a...

Treatment of donor-specific antibody-mediated rejection after heart transplantation by ...
https://doi.org/10.1002/ehf2.13409
ESC Heart Failure; Immohr MB, Akhyari P et. al.

May 10th, 2021 - Antibody-mediated graft rejection caused by donor-specific antibodies (DSA-MR) remains a serious problem after heart transplantation (HTx). IgM-enriched human intravenous immunoglobulin (IGM-IVIG) consists of 76% IgG, 12% IgM, and 12% IgA and prov...

Boolean analysis of the transcriptomic data to identify novel biomarkers of IVIG response.
https://doi.org/10.1016/j.autrev.2021.102850
Autoimmunity Reviews; Rambabu N, Mathew MJ et. al.

May 10th, 2021 - Intravenous immunoglobulin (IVIG) is used to treat several autoimmune and inflammatory diseases, but some patients are refractory to IVIG and require alternative treatments. Identifying a biomarker that could segregate IVIG responders from non-res...

see more →

Guidelines  7 results

European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatol...
https://doi.org/10.1111/jdv.13725
Journal of the European Academy of Dermatology and Venere... Enk AH, Hadaschik EN et. al.

Oct 20th, 2016 - The treatment of severe dermatological autoimmune diseases and toxic epidermal necrolysis (TEN) with high-dose intravenous immunoglobulin (IVIg) is a well-established procedure in dermatology. As treatment with IVIg is usually considered for rare ...

CONSENSUS STATEMENT: THE USE OF INTRAVENOUS IMMUNOGLOBULIN IN THE TREATMENT OF NEUROMUSCULAR...
http://www.aanem.org/getmedia/e39a0191-ee38-48fe-9b43-e580228825a7/IVIG_CS_2009.pdf
PETER D. DONOFRIO

Sep 17th, 2009 - Consensus statements are important for developing treatment recommendations when evidence- based medicine (EBM) and treatment based on controlled trials is sparse or nonexistent. In this setting, it is clinically helpful to assemble a group of exp.

When the Guillain-Barre patient fails to respond to treatment.
https://doi.org/10.1136/jnnp.2009.176578
Practical Neurology; Winer JB

Jul 17th, 2009 - Most patients with Guillain-Barré syndrome (GBS) respond to treatment with intravenous immunoglobulin, but it is not uncommon for some to continue to deteriorate for a period after treatment has been started. This may reflect the natural history o...

Guidelines on the use of high-dose intravenous immunoglobulin in dermatology.
https://doi.org/10.1684/ejd.2008.0580
European Journal of Dermatology : EJD; Enk A,

Jan 27th, 2009 - The treatment recommendations presented for the use of IVIg in dermatology highlight the high status of IVIg therapy in numerous defined dermatological autoimmune diseases and in toxic epidermal necrolysis. The high value of IVIg therapy in diseas...

EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological ...
https://doi.org/10.1111/j.1468-1331.2008.02246.x
European Journal of Neurology; Elovaara I, Apostolski S et. al.

Sep 17th, 2008 - Despite high-dose intravenous immunoglobulin (IVIG) is widely used in treatment of a number of immune-mediated neurological diseases, the consensus on its optimal use is insufficient. To define the evidence-based optimal use of IVIG in neurology, ...

see more →

Clinicaltrials.gov  5,221 results

Intravenous immunoglobulin in COVID-19 associated Guillain-Barré syndrome in pregnancy.
https://doi.org/10.1136/bcr-2021-242365
BMJ Case Reports; Garcia JJ, Turalde CW et. al.

May 12th, 2021 - The COVID-19 pandemic has led to a rise in cases of Guillain-Barré syndrome (GBS). This autoimmune sequela is a manifestation of the neurotropism potential of the virus. At present, knowledge regarding the pathophysiology, clinical features, manag...

Nivolumab induced systemic capillary leak syndrome as an ultra rare life-threatening ph...
https://doi.org/10.2217/imt-2020-0335
Immunotherapy Polishchuk I, Yakobson A et. al.

May 10th, 2021 - Systemic capillary leak syndrome (SCLS) is a life-threatening disease. It is characterized by severe capillary hyperpermeability to proteins resulting in hemoconcentration, hypoalbuminemia and hypovolemic shock. Its treatment remains supportive, a...

Treatment of donor-specific antibody-mediated rejection after heart transplantation by ...
https://doi.org/10.1002/ehf2.13409
ESC Heart Failure; Immohr MB, Akhyari P et. al.

May 10th, 2021 - Antibody-mediated graft rejection caused by donor-specific antibodies (DSA-MR) remains a serious problem after heart transplantation (HTx). IgM-enriched human intravenous immunoglobulin (IGM-IVIG) consists of 76% IgG, 12% IgM, and 12% IgA and prov...

Boolean analysis of the transcriptomic data to identify novel biomarkers of IVIG response.
https://doi.org/10.1016/j.autrev.2021.102850
Autoimmunity Reviews; Rambabu N, Mathew MJ et. al.

May 10th, 2021 - Intravenous immunoglobulin (IVIG) is used to treat several autoimmune and inflammatory diseases, but some patients are refractory to IVIG and require alternative treatments. Identifying a biomarker that could segregate IVIG responders from non-res...

see more →

News  159 results

Corticosteroids Appear to Prevent Coronary Abnormalities in Kawasaki Disease
https://www.medscape.com/viewarticle/936080

Aug 20th, 2020 - NEW YORK (Reuters Health) - Addition of corticosteroids to initial intravenous immunoglobulin (IVIG) treatment appears to reduce the rate of coronary-artery abnormalities in high-risk patients with Kawasaki disease, according to a nationwide surve...

First autoimmune epilepsy RCT supports IVIG therapy
https://www.mdedge.com/neurology/epilepsyresourcecenter/article/214674/epilepsy-seizures/first-autoimmune-epilepsy-rct?channel=53
M. Alexander Otto

Dec 20th, 2019 - BALTIMORE – Six of eight people (75%) with leucine-rich, glioma-inactivated-1 (LGI-1) antibody–associated epilepsy had at least a 50% reduction in seizure frequency with intravenous immunoglobulin (IVIG) versus none of six randomized to placebo in.

Thromboembolic events more likely among CIDP patients with CVAD
https://www.mdedge.com/emergencymedicine/article/211151/neuromuscular-disorders/thromboembolic-events-more-likely-among?channel=350
Tara Haelle

Oct 29th, 2019 - AUSTIN, TEX. – Patients with chronic inflammatory demyelinating polyneuropathy (CIDP) who receive intravenous immunoglobulin (IVIg) appear to have an increased risk of thromboembolic events if it is administered with a central venous access device.

A 36-Year-Old Woman With a Worsening Cough and Hearing Loss
https://reference.medscape.com/viewarticle/917371_5

Sep 4th, 2019 - The primary treatment for EGPA is systemic glucocorticoids. In addition, an immunosuppressive agent is typically added for advanced refractory disease. Various disease-modifying agents have been used as glucocorticoid-sparing or maintenance therap...

Successful Treatment of Refractory Epidermolysis Bullosa Acquisita With Intravenous Immunoglobulin and Dapsone
https://www.mdedge.com/dermatology/article/207149/mixed-topics/successful-treatment-refractory-epidermolysis-bullosa?channel=44
Justin M. McLawhorn, MD, Andrew W. Johnson, MD et. al.

Aug 27th, 2019 - To the Editor: Evidence-based recommendations for optimal medical management of patients with immunobullous diseases prior to elective surgery are sparse. 1,2 There is an uncertain balance between the use of immunomodulators and immunosuppressants,.

see more →

Patient Education  1 results see all →